Niki BioSolutions annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
Niki BioSolutions Operating Expenses Growth & History (NIKI)
Niki BioSolutions's operating expenses was $1.8M for fiscal 2025.
View full Niki BioSolutions company overviewNiki BioSolutions annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.8M | −$2.1M | −53.88% |
| 2024 | 2024-12-31 | $3.9M | −$7.2M | −64.68% |
| 2023 | 2023-12-31 | $11.2M | −$7.6M | −40.68% |
| 2022 | 2022-12-31 | $18.8M | −$1.9M | −9.37% |
| 2021 | 2021-12-31 | $20.7M | −$437,837 | −2.07% |
| 2020 | 2020-12-31 | $21.2M | $2.5M | +13.10% |
| 2019 | 2019-12-31 | $18.7M | $8.0M | +74.89% |
| 2018 | 2018-12-31 | $10.7M | $5.0M | +88.15% |
| 2017 | 2017-12-31 | $5.7M | — | — |
Niki BioSolutions quarterly operating expenses
Q4.24
Q3.25
Q4.25
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $825,131 | $1.4M | — |
| Q3 2025 | 2025-09-30 | $589,631 | — | — |
| Q4 2024 | 2024-12-31 | −$558,599 | — | — |
Niki BioSolutions operating expenses trends
Over the last five fiscal years, Niki BioSolutions's operating expenses decreased from $21.2M to $1.8M, a change of −$19.4M. The latest reported quarter, Q4 2025, shows $825,131.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗